Oncology Books
Xlibris Diagnosis: Cancer
Book Synopsis
£11.20
Cold Spring Harbor Laboratory Press Modeling Cancer in Mice
Book Synopsis
£71.10
Thieme Medical Publishers Inc Lung Cancer Screening
Book SynopsisLung cancer is the leading cause of cancer-related death among men and women in the U.S. and worldwide. For many decades, lung cancer was the sole cancer among the deadly four without an evidence-based screening method for decreasing mortality. This changed in November 2011, when findings from the National Lung Cancer Screening Trial showed low-dose lung CT screening was more efficacious in reducing deaths in high-risk individuals than conventional radiography. As such, an ever-increasing number of health organizations now recommend this screening protocol. Lung Cancer Screening by Mark Parker and esteemed VCU Health colleagues, fulfills the dire need for a comprehensive guide explaining the crucial aspects of lung cancer screenings. The first two chapters lay a foundation with discussion of lung cancer epidemiology and risk factors beyond cigarette smoking. Subsequent chapters cover the fundamentals, with clinical pearls on setting up a successful lung cancer screening program, patient eligibility criteria, imaging variances of tumors in the lungs, screening pros and cons, and interpreting/reporting screening results. The evolution and future of lung cancer screenings Detection and management of unexpected incidental pulmonary and non-pulmonary findings Discussion of test cases utilizing the Lung-RADSTM risk-stratifying system for low-dose chest CT screenings Benefits and potential harms associated with mass lung cancer screening programs including false positive, false negative, and over-diagnosis rates This state-of-the-art guide is essential reading for radiologists, oncologists, pulmonologists, and internists. It is a must-have bookshelf reference for hospital radiology and oncology departments, in particular for those setting up new lung cancer screening programs.Table of Contents1 Lung Cancer Epidemiology 2 Risk Factors for Lung Cancer 3 Evolution of Lung Cancer Screening 4 Lung Cancer Screening Pros and Cons 5 Variable Imaging Presentations of Lung Cancer 6 Lung Cancer–Screening Results Reporting 7 Detection and Management of Unexpected Incidental Pulmonary and Nonpulmonary Findings 8 Elements of a Successful Lung Cancer–Screening Program 9 Future of Lung Cancer Screening 10 Test Cases: Applying Lung CT Screening Reporting and Data System (Lung-RADS)
£52.72
Camino Books Cancer and Vitamin C 21st-Century Edition: A
Book Synopsis
£25.16
Wolters Kluwer Health Understanding Skin Cancer Anatomical Chart
Book SynopsisUnderstanding Skin Cancer Anatomical Chart, Third Edition, is a highly illustrated chart providing clear, easy-to-understand information on skin cancer, now fully up to date with treatment information for each type of condition/cancer discussed and updated drawings and photographs. It defines and depicts precancerous growths, atypical moles, and malignant melanoma and nonmelanoma, as well as skin cancer prevention and self-examination. This edition includes updated drawings with inclusive representation and condition photos shown on various skin tones.Featured sections: Risk Factors Precancerous Growths Atypical Moles Types of Skin Cancer (Nonmelanoma) Malignant Melanoma Skin Cancer Prevention Self-Examination Self-examination illustrations Illustrations and photographs included: Anatomical illustration of skin layers Self-examination illustrations Actinic keratoses, atypical nevus, basal cell carcinoma, and squamous cell carcinoma Malignant melanoma with examples of "ABCDE" features (asymmetry, border, color, diameter, evolving) 20" x 26" heavy paper laminated with grommets at top cornersTable of ContentsSections/Headings: Overview Risk Factors Pre-Cancerous Growths Atypical Moles Types of Skin Caner (Non-Melanoma) Malignant Melanoma (MM) Skin Cancer Prevention Self-Examination Illustrations included: Anatomical illustrations of skin layers Series of self-examination illustrations Photographs included: actinic keratoses atypical nevus basal cell carcinoma (BCC) squamous cell carcinoma (SCC) malignant melanoma with examples of "ABCDE" features (asymmetry, border, color, diameter, evolving)
£31.88
Springer International Publishing AG Integrative Oncology in Breast Cancer Care
Book SynopsisIntegrative Oncology (IO) is an evolving evidence-informed field of medicine with little high-quality professional literature currently available to support clinical practice. This book provides a robust introduction to integrative oncology and a practical toolkit for clinicians working with breast cancer patients. Breast cancer is the commonest cancer in women globally with growing incidence, and breast cancer patients are the most frequent users of integrative oncology practices. This book addresses the whole person journey from prevention, to diagnosis, treatment and survivorship. The approaches and tools discussed can help guide clinicians on how to support better quality of life, improve patient resilience, minimise the side effects of treatment and optimise clinical outcomes for people impacted by breast cancer. Healthcare professionals are asking for further education on Integrative Oncology, as evidenced by the BSIO (British Society for Integrative Oncology) survey results, webinars and conference engagements. Our growing BSIO membership highlights the need to educate and train healthcare professionals, and this book is written by clinicians for clinicians.Table of ContentsIntroduction.- PART ONE . Breast Cancer Prevention and Diagnosis.- Chapter 1 . Prevention is better than Treatment .- Chapter 2 . Personalised Breast Screening: A Mammogram for all? .- Chapter 3 . The Diagnosis dilemma: do we know the Why? .- Chapter 4 . Integrative Oncology matters: Building the Foundations .- PART TWO. Early Breast Cancer .- Chapter 5 . Before and After Breast Surgery.- Chapter 6 . Living with not just surviving Chemotherapy.- Chapter 7 . Radiotherapy: when, what and how.- Chapter 8 . Managing the impact of hormone therapy.- Chapter 9 . Targeted therapies and immunotherapy .- PART THREE. Living Well with Advanced Breast Cancer.- Chapter 10 . No cure versus chronic illness: shifting the paradigm.- Chapter 11 . Integrating Therapies - a rational, personalised approach to metastatic disease.- Chapter 12 . Symptomatic Care is a Whole Team approach.- Chapter 13 . Experiencing the End of Life.- PART FOUR . Survivorship.- Chapter 14 . Early survivorship – rehabilitation and reintegration.- Chapter 15 . Managing long-term health risks for breast cancer survivors.
£58.49
Springer Hematological Cancer Pathophysiology An
Book Synopsis
£170.99
De Gruyter Probleme der Krebsforschung und Krebsbekämpfung
Book Synopsis
£123.33
de Gruyter Jahrestagung Der Deutschen Akademie Der
Book Synopsis
£134.09
De Gruyter Die parasagittalen Meningiome
Book Synopsis
£122.35
Kohlhammer Erweiterte S3-Leitlinie Palliativmedizin Fur
Book Synopsis
£37.80
Birkhauser Verlag AG Molecular Determinants of Head and Neck Cancer
Book SynopsisSquamous cell cancers of the head and neck (SCCHN), also known as head and neck cancers (HNC) encompass malignancies of the oral cavity, larynx, nasopharynx and pharynx, and are diagnosed in over 500,000 patients worldwide each year, accounting for 5% of all malignancies. It is estimated that approximately 50,000 patients develop head and neck cancer annually in the United States, of whom approximately 50% succumb to this cancer. For most cases of SCCHN, treatment is multimodal, often combining surgery or irradiation with chemotherapy; even successfully treated patients frequently experience durable and severe side effects. Improving cure rates and reducing chronic morbidity are urgent clinical needs for head and neck cancer. However, in contrast to cancer types such as breast or prostate that have been much studied and have well-defined biology, until recently, relatively few researchers investigated the molecular basis of HNC, making it difficult to design targeted treatments with better efficacy and less debilitating side effects. This volume will provide an overview of the factors contributing to disease pathogenesis, including the recognition of discrete molecular subtypes with distinct etiology, prognosis, and treatment response. This volume will familiarize the reader with the critical signaling pathways and oncogenic drivers for HNC. It will outline the differences between HPV-positive and HPV-negative disease, and how these differences affect treatment choice and outcome. The book will emphasize developments in the past five years, including the growing understanding of the genomic and epigenomic features of the disease based on analysis of next generation sequencing (NGS) data, and timely topics such as the analysis of HNC stem cell populations, non-coding mRNAs, and inflammatory response. It will address exciting new therapeutic approaches such as the use of immunotherapies to treat HNC patients. Overall, the book will provide the reader with current understanding of the biology and treatment of the disease, and describe timely questions that will guide future research aimed at controlling and curing this disease.Trade Review“The book is intended primarily for clinicians, fellows, interns, and trainees, but medical students who may be interested in head and neck cancer but face the challenge of updating themselves on the latest innovations may also find this book very useful. … this is an informative and authoritative book on the subject that includes experiences from clinicians and scientists working on head and neck cancer at some of the most renowned cancer centers in the world.” (Ravi Salgia, Doody's Book Reviews, March, 2019)Table of ContentsChapter 1: Overview: B. Burtness and E. GolemisChapter 2: HER inhibition in HNC: E. Golemis and B. BurtnessChapter 3: MET: T Beck, Fox Chase Cancer CenterChapter 4: PI3K/mTOR/AMPK: C. Chung, Moffit Cancer CenterChapter 5: Jak/STAT: J.R. Grandis, UCSFChapter 6: TGFb: Neiman and Wang, University of ColoradoChapter 7: Wnt and catenin Signaling: MA Kukurusinska, Boston UniversityChapter 8: P53/p63/p73: B. BurtnessChapter 9: DNA damage: R. Bindra, Yale UniversityChapter 10: APOBEC Proteins: K.S. Anderson, Yale UniversityChapter 11: Hypoxia, including HIF1: Q. Le, Stanford UniversityChapter 12: VEGF/Angiogenesis and Antiangiogenic Therapy: A Argiris, Thomas Jefferson UniversityChapter 13: Sequencing/genomic insights: J.Myers, MD AndersonChapter 14: Gene expression, Methylation, and histones: R.Mehra, A.Andrews, S.Peri, Fox Chase Cancer Center and A.Bhatia, Yale UniversityChapter 15: Inflammation: Carter Van Waes, NIHChapter 16:Immunotherapy: Ferris and Baumann, UPMCChapter 17: FAK/Integrin pathway inhibitors: Nils Cordes, DresdenChapter 18: Targeting cell cycle controls: E.GolemisChapter 19: Head and neck cancer stem cells: L.Bourguignon, UCSFChapter 20: Non-coding RNAs: C.Punyadeera, Queensland UniversityChapter 21: Epidemiology of HPV: Ragin and Lui, Fox Chase Cancer CenterChapter 22: DNA damage in HPV-positive SCCHN: WG Yarbrough, Yale UniversityChapter 23: Treatment paradigms in HPV-positive SCCHN: A Cmelak, Vanderbilt University
£999.99
Urban & Fischer/Elsevier TherapieHandbuch Dermatologie und Allergologie
Book Synopsis
£35.10
Urban & Fischer/Elsevier TherapieHandbuch Rheumatologie und Immunologie
Book Synopsis
£35.10
Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Aktinische Keratosen (Carcinomata in situ)
Book SynopsisTable of ContentsHistorie.- Klinisches Bild und Verlauf.- Histopathologie.- Risikofaktoren und Prävention.- Molekulare Tumorgenese-ein Schlüssel zum Verständnis der Dynamik aktinischer Keratosen.- Therapie.- Wertung und Schlussbetrachtung.- Literatur.
£999.99
Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Krankheit: Lernen im Ausnahmezustand?: Brustkrebs
Book SynopsisWer an einer lebensbedrohlichen Krankheit leidet, dem hilft eine Fähigkeit besonders: das Lernen. Am Beispiel von Brustkrebs- und Herzinfarktpatienten zeigt ein Forscherteam in interdisziplinärer Perspektive, wie Lernprozesse im Ausnahmezustand einer lebensbedrohlichen Krankheit gelingen können. Der Band richtet sich an Psychotherapeuten, Psychiater, Ärzte sowie Lehrende und Forscher dieser Fächer und liefert Krankengeschichten in pseudonymisierter Form, die sich für weitere wissenschaftliche Analysen, aber auch für den Einsatz in der Lehre eignen.Trade Review“… Dieses Werk ist nicht nur umfangreich, sondern auch inhaltlich reich an Anregungen, wie mit lebensbedrohlichen Krankheiten umgegangen wird bzw. umgegangen werden kann. ... Es ist in jeder Hinsicht aufklärend und spannend in den Ausführungen und lässt sich sicherlich sinnvoll für die Ausbildung von kasuistischer Kompetenz im Gesundheitsbereich einsetzen. Auch ist es für weitere interdisziplinäre Forschungen zu Prozessen von Lernen und Nicht-Lernen anregend. ... Ein sehr empfehlenswertes Buch, nicht nur für die Erwachsenenbildung.” (Anne Schlüter, in: Zeitschrift für Weiterbildungsforschung, Jg. 38, 2015)Table of ContentsI Standpunkte wissenschaftlicher Disziplinen: 1 Nittel/Seltrecht, Einleitung: Vom Wert einer vergleichenden Sicht auf Krankheit.- 2 Fink/Behrens, "Fakten und Zahlen" zu Brustkrebs und Herzinfarkt.- 3 Lüngen/Passon, Gesundheitsökonomie: Die Finanzierung von Prävention und Behandlung von Herzinfarkt und Brustkrebs.- 4 Gerlinger, Disease-Management-Programme für Brustkrebs und koronare Herzkrankheit.- 5 Beuth/Baumann, Brustkrebs koronare Herzkrankheit.- 6 Banzer/Vogt/Thiel, Wirkung und Steuerung körperlicher Aktivität in der Therapie von Brustkrebs und Herzinfarkt.- 7 Meyer-Drawe, Lernen und Leiden. Eine bildungsphilosophische Reflexion.- 8 Heinritz, Zwei frühe Selbstzeugnisse von Frauen über Brustamputationen nach Krebserkrankung.- 9 Brumlik, Arge Lernprozesse – Thomas Mann über Tod, Krankheit und Bildung.- II Patientenperspektiven: 10 Seltrecht/Nittel, Phänomenologie der Krankheiten: Brustkrebs und Herzinfarkt.- 11 Keil, Krankheit als biographischer Ausnahmezustand: Der objektive Faktor Subjektivität.- 12 Nittel, Prozessuale Lerndimensionen: Instrumente zur Erschließung von Lernprozessen bei Patienten mit lebensbedrohlichen Erkrankungen.- 13 Schmitt, Metaphern für Bildungsprozesse im Kontext von Krankheitserfahrungen.- 14 Fischer, Biographie, Leib und chronische Krankheit.- 15 Dinkelaker, Formen und Ressourcen der Eigensinnigkeit: Varianten der Uneinsichtigkeit einer Herzinfarktpatientin.- 16 Schaeffer/Haslbeck, Komplexe Medikamentenregime bei chronischer Krankheit – diskutiert am Beispiel kardiologischer Erkrankungen.- 17 Alheit, „Da wurde man, auf Deutsch gesagt, so richtig in heißes Wasser geschmissen“: Der Herzinfarkt als „politisches“ Phänomen?- 18 Fingerle/Bonnes, Der Krankheitsverlauf bei einer Brustkrebspatientin aus der Perspektive der Resilienzforschung.- 19 von Kardoff/Schönberger, Krebskranke in Rehabilitation und Nachsorge: Lebensgeschichtliche Transformationsprozesse zwischen Gestaltwandel und Kontinuierung.- 20 Gröning, Der verlorene Körper: Scham und Isolierung als Grundproblem einer Brustkrebspatientin.- 21 Oswald/Himmelsbach, Entwicklung unter der Bedingung einer lebensbedrohlichen Erkrankung im Alter.- 22 Haker, Die Relevanz religiöser und ethischer Orientierungen bei der Bewältigung von Krankheit.- 23 Fuchs-Heinritz, Herr Adler wird vernünftig. Veränderungen der Lebensauffassung und des Todesbildes nach einem Herzinfarkt.- 24 Seltrecht, Vertrauen und Hoffnung: Zur Relevanz dieser Untersuchungskategorien für die Aufdeckung von Lernprozessen.- 25 Friebertshäuser/Richter, Brustkrebs als Statuspassage: Leben und Sterben als Krise und Lösung.- 26 Seltrecht, Lernen im Angesicht des Todes?- 27 Hoyer, Die Passage des Sterbens: Krebserkrankung im Spielfilm.- III Die Sicht der Professionellen: 28 Dierks, Die Patientenuniversität: Krankheit als Lerngegenstand.- 29 Jäger/Neumann, Klinische Studien und Nachwuchswissenschaftler in der Onkologie.- 30 Herrmann/Lehmann, Herzinfarkt aus Sicht der Allgemeinmedizin.- 31 Senf/Kaiser, Brustkrebs als Auslöser von psychosozialen Belastungen, Angst und Depression sowie Methoden, Effekte und Angebote psychoonkologischer Interventionen.- 32 Haubl, Lebensgeschichtliche Erfahrung und berufsbiographische Entscheidungsprozesse eines Psychoonkologen.- 33 Schäfer, Fernsehserien als Lernvorlage: Was können wir von „Dr. House“ lernen?- 34 Hoppe, Transfer erziehungswissenschaftlich generierten Wissens in die medizinische Ausbildung in Form von E-Learning-Modulen.- IV Der Blick auf die Arzt-Patient-Interaktion: 35 Brockmann, Die ärztliche Aufklärung als Rechtspflicht in der Arzt-Patient-Beziehung.- 36 Reineke/Spranz-Fogasy, Arzt-Patient-Kommunikation: Allgemeine Merkmale und Besonderheiten bei Brustkrebspatienten.- 37 Vogd, Arzt-Patient-Interaktion aus medizinsoziologischer Perspektive.- 38 Kuczyk, Der Arzt als Wissensvermittler. Eine Analyse ärztlicher Vorträge vor Brustkrebspatientinnen.- 39 Nittel/Seltrecht, Die ärztliche Vermittlung aus Patientenperspektive.- 40 Detka, Aneignungsprozesse bei Patienten aus Ärztesicht.- 41 Oevermann, „Compliance“ und die Strukturlogik des Arbeitsbündnisses zwischen Arzt und Patient.- 42 Herzberg, Die biographische Herausforderung in der Brustkrebs-Pflege: Über die Notwendigkeit, Patienten wirklich zu verstehen.- 43 Hampe, Die Förderung therapeutischer Prozesse bei Brustkrebspatienten durch Kunsttherapie.- 44 Lammer, „Lehre uns bedenken, dass wir sterben müssen, damit wir ein weises Herz gewinnen“ (Psalm 90).- 45 Seltrecht, „… das sollten Ärzte nicht machen“ – Ärztefehler und medizinische Fehler unter erziehungswissenschaftlicher Perspektive.
£999.99
Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Management des Lungenkarzinoms
Book SynopsisInterdisziplinärer Überblick über die verschiedenen Diagnoseverfahren sowie die chirurgischen, radiologischen und chemotherapeutischen Behandlungsmethoden. Einzigartig in der klinikbezogenen Darstellung!Trade ReviewFür die Versorgung von Tumorpatienten sind spezialisierte onkologische Zentren ebenso bedeutsam wie die Gewährleistung von Qualitätsstandards bei der Breite der betreuenden Ärzte. Das betrifft die Effektivität und Qualität von Diagnostik und Therapie gleichermaßen, wie die Sicherung der bestmöglichen Lebensqualität. Das Buch "Management des Lungenkarzinoms", herausgegeben von Drings, Dienemann und Wannenmacher, aus der Reihe "Onkologie aktuell" des Springer-Verlags trägt beispielhaft dazu bei. Dem Spezialisten bietet es einen guten Überblick und der Breite der betreuenden Ärzte eine gut verständliche und rasche Orientierung zu allen Aspekten, die das Lungenkarzinom betreffen. Die 26 gut lesbaren Kapitel sind gespannt von der Epidemiologie und Molekularbiologie, über Konzepte der Vorsorge und des Screenings zu diagnostischen Methoden und deren Bewertung, den verschiedenen Therapiemodalitäten und den Algorithmen der Behandlung bis hin zu Entwicklungsperspektiven künftiger Therapiekonzepte. Wichtige Informationen von Praxisrelevanz sind im Text gut erkennbar als praktische Tipps herausgehoben. Die Autoren sind renommierte Experten auf ihrem Feld und als Pneumologe, Onkologe, Thoraxchirurg, Pathologe wie auch als klinischer Forscher mit dem Management des Lungenkarzinoms in ihrer täglichen Praxis befaßt. Die Autoren verdienen hohe Anerkennung für ein Buch, das in dieser auf die Klinik bezogenen Zielsetzung für das Lungenkarzinom bisher nicht vorliegt und einen Qualitätsstandard auf bestem Niveau für das Management dieses Tumors bietet. Es kann jedem, der mit der Betreuung dieser Patienten befaßt ist, nur empfohlen werden.Table of ContentsI Anatomie, Ätiologie, Epidemiologie und Molekularbiologie.- 1 Anatomie und Physiologie der Lunge.- 2 Ätiologie und Epidemiologie.- 3 Molekulargenetische Aspekte, Tumorbiologie und Mechanismen der Metastasierung.- II Vorsorge und Früherkennung.- 4 Neue Aspekte der Früherkennung und des lokalen Stagings.- III Diagnostik, Pathologie und Stadieneinteilung.- 5 Diagnosesicherung und prätherapeutische Diagnostik.- 6 Endoskopische Diagnostik.- 7 Radiologische Diagnostik des Bronchialkarzinoms — Projektionsradiographie und Computertomographie.- 8 Magnetresonanztomographie.- 9 Positronenemissionstomographie (PET).- 10 Tumor-Marker — Bedeutung für Diagnostik und Verlaufskontrolle.- 11 Pathologie, Klassifikation und Stadieneinteilung.- IV Therapie.- 12 Geschichte der Behandlung der Lungenkarzinome.- 13 Nichtkleinzellige Lungenkarzinome.- 14 Kleinzellige Lungenkarzinome.- 15 Bronchuskarzinoid.- 16 Seltene Lungentumoren.- 17 Therapie isolierter Metastasen.- 18 Tumorbedingte Komplikationen.- 19 Therapiebedingte Komplikationen und Spätfolgen nach Operation, Radio- und Chemotherapie.- V Nachsorge und Prognose.- 20 Nachsorge und Rehabilitation.- 21 Psychoonkologie und Lebensqualität.- 22 Chemoprävention.- VI Zukunftsperspektiven.- 23 Videoassistierte Thoraxchirurgie (VATS) — Weiterentwicklung, robotergesteuerte Therapie.- 24 Verbesserung der Strahlentherapie bei der Behandlung des Lungen- karzinoms.- 25 Neue therapeutische Ansätze in der internistischen Therapie nicht- kleinzelliger Lungenkarzinome.- 26 Molekulare Prognosefaktoren.
£83.70
Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Krebs: Neue Chancen auf Gesundheit
Book SynopsisKrebs ist besser behandelbar geworden, als die meisten Menschen vermuten. Schon heute können 2 von 3 Patienten mit Krebs dauerhaft geheilt werden. Das Sachbuch vermittelt in kompakter und gut verständlicher Form das derzeitige Wissen über Krebs. Die Ursachen und die Entstehung der Krebserkrankung werden erklärt und die modernen, personalisierten Strategien zur Vorbeugung und Therapie vorgestellt.Die 2. Auflage wurde auf den aktuellen Stand gebracht und informiert über die neuesten Therapien. Direkt umsetzbare Ratschläge zeigen, wie man sich effektiv vor Krebs schützen kann. Zehn praxisnahe, konkrete Empfehlungen aus der langjährigen Erfahrung des Autors geben dem von einer Krebserkrankung Betroffenen Rat und Orientierung.Trade Review“... Das informative und leicht verständliche Sachbuch ist für Laien geschrieben, aber auch für Angehörige der Gesundheitsberufe eine empfehlenswerte Lektüre.” (PZ Pharmazeutische Zeitung, 31. März 2023)Table of Contents
£999.99
IAEA Advances in Boron Neutron Capture Therapy
Book SynopsisBoron neutron capture therapy (BNCT) is a neutron-based technique that allows selective cancer treatment at the tumour cellular level. BNCT is especially suitable for the treatment of brain, head, neck and skin cancers. Using the reaction between a neutron and boron to selectively destroy cancer cells, BNCT is a treatment that differs radically from conventional radiotherapy and promises to become a more widely adopted option for cancer treatment. BNCT is undergoing a major resurgence of interest around the world as some recent progress in accelerator technology allows the procedure to be undertake in clinics. In addition, the approval of BNCT in Japan as a routine clinical treatment for certain tumour types offers valuable insights for other states considering a similar approach. This publication comprehensively reports on the current state of the science as well as the supporting technology. It covers accelerator-based neutron sources, beam design, physical dosimetry, facility design and operation, pharmaceuticals, radiobiology, dose calculation, treatment planning and clinical trials. It has been written to assist in decision making at the national level as well as offering practical guidance for all those involved in implementation and ongoing management of BNCT programmes.
£47.70
Springer Verlag, Singapore Handbook of Oxidative Stress in Cancer:
Book SynopsisThis reference book, which is the second volume of Targeting Oxidative Stress in Cancer, explores oxidative stress as the potential therapeutic target for cancer therapy. The initial chapters discuss the molecular mechanisms of oxidative stress and its effects on different signaling pathways. Subsequently, the sections examine the impact of redox signaling on tumor cell proliferation and consider the therapeutic potential of dietary phytochemicals and nutraceuticals in reactive oxygen species (ROS)-induced cancer. In turn, it examines the evidence supporting the use of Vitamin C in cancer management, before presenting various synthetic and natural compounds that have therapeutic implications for oxidative stress-induced cancer. It also explores the correlation between non-coding RNA and oxidative stress. Furthermore, the book summarizes the role of stem cells in ROS-induced cancer therapy and reviews the therapeutic applications of nanoparticles to alter redox haemostasis in cancer cells. Lastly, it explores heat-shock proteins, ubiquitin ligases, and probiotics as potential therapeutic agents in ROS-mediated cancer. This book is a useful resource for basic and translational scientists as well as clinicians interested in the field of oxidative stress and cancer therapy. Table of ContentsSection A: Therapeutic implications of natural compounds Chapter 1 Natural dietary alkaloids and its synthetic derivatives as oxidative stress-inducing agents for cancer therapy Chapter 2. Role of antioxidants in the treatment of hepatocellular carcinoma Chapter 3. Antioxidants in cancer prevention Chapter 4. Therapeutic potential of natural agents against oxidative stress influenced colitis-associated cancer. Chapter 5. Prevention of fertility due to chemotherapy-induced ovarian failure: Role of therapeutic antioxidant Chapter 6 Human papiloma virus (HPV) related cancer, redox state and antioxidant therapy. Chapter 7. The effect of antioxidants on chemotherapy-induced apoptosis Chapter 8. Therapeutic potential of Natural antioxidants in Chemotherapeutic Agent Cyclophosphamide Associated Cardiotoxicity Chapter 9. Therapeutic implications of phytochemicals in ROS induced cancer Chapter 10. Nutraceuticals in cancer therapy: challenges and opportunities Chapter 11. Role of dietary antioxidants in chemoprevention of nitrosamines induced carcinogenesis. Chapter 12 Role of Rosmarinus officinalis (rosemary) essential oil in oxidative stress induced brain cancer Chapter 13 Therapeutic Flavonoids in cancer: ROS-mediated mechanisms Chapter 14 Protective effect of Quercetin, Luteolin, and Fisetin via stimulating the p53 mediated signaling in cancer. Section B: Therapeutic implications of synthetic compounds Chapter 15. Nitrogen- and sulfur-containing heterocycles as dual anti-oxidant and anti-cancer agents Chapter 16. Small molecule inhibitors that target signal transduction pathways involved in oxidative stress-induced cancer: current status and future directions. Chapter 17. Polyphenolic acetates as therapeutics and adjuvant in the therapy of Cancer. Chapter 18 Application of Peptides as cancer therapeutic Chapter 19 Retinoids and reactive oxygen species in cancer cell death and therapeutics. Chapter 20. Benzophenone-2 on oxidative stress induced brain cancer Chapter 21 Salubrinal promotes cisplatin resistance in human gastric cancer cells via enhabced xCT expression and glutathione biosynthesis. Chapter 22. Beyond natural antioxidants in cancer therapy: novel synthetic approaches in harnessing oxidative stress. Chapter 23. Evaluation of chalcore-linked pyrazole pyrimidines in oxidative stress induced breast cancer Chapter 24. Engineered biopolymer for post operated cancer wound healing Chapter 25. Role of TNF-α inhibitors in oxidative stress induced ovarian cancer Chapter 26. Oxidative stress induced colon cancer: effect of Tanshienone Chapter 27. PARP inhibitor olaparib in oxidative stress induced colon cancer Chapter 28. Prevention of ROS induced gastrointestinal carcinoma by synthetic compounds Section C : Radiation and photodynamic approaches in ROS induced cancer therapeutics Chapter 29 Radiotherapy and Oxidative Stress Chapter 30. Photodynamic therapy induced oxidative stress for cancer treatment. Chapter 31 Hybrid nanomaterials for photodynamic therapy Chapter 32. Cross-talk between ROS dependent apoptotic and autophagic signalling pathways in Zn(II) pththalalocyanine photodynamic therapy in melanoma Chapter 33 Elevating the reactive oxygen species in cancer cells by photodynamic therapy: Pro-oxidative approach for cancer treatment. Section D: Non-coding RNA in therapeutics of ROS induced cancer Chapter 34 Oxidative stress mediated miRNA regulation in cancer Chapter 35 Non-coding RNAs in the regulation of voltage gated anion channels: An emerging aspect of ROS induced cancer therapeutics Chapter 36. Exosomal non-coding RNAs: A future of therapeutics in regulating oxidative stress induced breast cancer. Chapter 37 Chapter miRNA and oxidative stress cross talk in cancer Chapter 38 miRNA-mediated oxidative stress induction in cancer Chapter 39. miRNA and oxidative stress cross talk in cancer Chapter 40. A Critical approach in the Analysis of lncRNA characteristics for Cancer Therapy Chapter 41. Long non coding RNA acting as therapeutic target for oxidative stress induced pancreatic cancer Chapter 42. Short non-coding RNAs: Emerging molecular players in therapeutics of ROS induced cancer Section E : Stem cells in therapeutics of ROS induced cancer Chapter 43. Colon cancer stem cells: Target for treatment of oxidative stress induced colorectal cancer Chapter 44. Therapeutic modalities regarding ROS in leukemia and hematopoietic stem/progenitor cell perspective Chapter 45.Stemness and stromal niche: Targets in oxidative stress induced oral cancer Chapter 46. Targeting developmental pathways in Stem Cell for the therapy of Cancer Chapter 47. Cancer stem cell oxidative phosphorylation: Target for cancer therapy. Chapter 48. Targeting oxidative stress specific NRF2 in pancreatic cancer stem cells Chapter 49. Stem cells in ROS induced cancer therapy. Section F: Nanotechonology based therapeutics of ROS induced cancer Chapter 50 Role of natural polyphenols against toxicity induced by oxidative stress in cancer cells.Title: The multifaceted function of nanoparticles in modulating oxidative stress for cancer therapy Chapter 51. Emerging role of redox active nanoceria in cancer therapeutics via oxidative stress Chapter 52. Nano technology in ROS induced cancer therapy. Chapter 53. Nanotechnology-based ROS triggered therapeutic strategies in cancer. Chapter 54. Nanotechnology in cancer diagnosis and therapy Chapter 55. Emerging Nano selenium: An insight to its current Status and potentials in ROS induced cancer Prevention and Therapy' Chapter 56. Oxidative Stress-dependent Anticancer Potentiality of Nano-therapeutic Zinc Oxide Section G: Bioinformatics and system biology approach for targeting ROS in cancer therapy Chapter 57 Molecular insights into the roles of E3 ligases in ROS mediated cancer from a bioinformatics perspective Chapter 58 Elucidation of possible role of heat shock protein as potent therapeutic agent in ROS mediated cancer and its assessment through computational biology methods. Chapter 59. Dynamical methods to study interaction in proteins facilitating molecular understanding of ROS induced cancer Chapter 60. Role of Meprin in therapeutics of ROS induced cancer Chapter 61. Different databases and their utilities to in analyzing ROS mediated cancer Section H: Other aspects of therapeutics of ROS induced cancer Chapter 62 A CRISPR-Cas based therapeutics in oxidative stress-induced cancer. Chapter 63. Role of hypoxia in ROS induced cancer therapy Chapter 64. Syed Ehtaishamul Haque < Chapter 65. Molecular mechanism of oxidative stress in cancer and its therapy Chapter 65. Pro-apoptotic effects of dietary flavonoids in oxidative stress-induced cancer. Chapter 66. Redox signalling: hallmarks of cancer progression and resistance to treatments Chapter 67 Mechanistic and therapeutic crosstalk of lipid peroxidation in oxidative stress and breast cancer. Chapter 68. Targeting Myeloid Leukemia via ROS and Oxidative Stress Chapter 69. Immunotherapeutic approaches for treatment of oxidative stress in haematological malignancies Chapter 70 Application of regulating ROS in overcoming cancer multidrug resistance Chapter 71. Y-Box binding protein 1: A promising therapeutic target for cancer relapses. Chapter 72. Microbes induced oxidative stress for cancer development and therapeutic role of probiotics Chapter 73. Implications of ROS in Endometriosis and Ovarian cancer: Potential avenue in cancer therapy. Chapter 74.Implications of oxidative stress in autophagy and its connection with apoptosis in carcinogenesis Chapter 75. Role of Forkhead box proteins regulating epithelial mesenchymal transition in breast cancer.
£999.99
Springer Verlag, Singapore Cancer in the Arab World
Book SynopsisThis is an Open Access book. This book is a must-have for healthcare providers and researchers, public health specialists and policy makers who are interested and involved in cancer care in the Arab world. The Arab world consists of 22 countries, which are members of the Arab League and spanning over 13,132,327 km2 with over 423,000,000 population. Over the past few decades, the Arab world has witnessed a swift evolution in healthcare provision. Nonetheless, Arab countries have considerable variability in economic capabilities, resource allocation, and intellectual talent that inevitably reflect on access to modern cancer care and prevention. This book is authored by experts from the Arab world who provide vital information on cancer statistics and risk factors, available clinical care pathways and infrastructure, and prevention programs in their individual countries. The chapters also address specific challenges in each country and insights into future directions to achieve optimal care with conventional and novel diagnostics and therapies to keep up with the era of precision medicine. Special topics of interest and unique to the Arab world are also discussed, such as out of the country’s medical tourism for cancer care and cancer care during war and conflict. Other special chapters include: Cancer research in the Arab world, Radiation therapy in Arab World and Pediatric Oncology in the Arab World Cancer in the Arab World is the first comprehensive book that addresses cancer care in depth in all Arab countries and it is endorsed by the prestigious Emirates Oncology Society.Table of Contents 1 Introduction 2 General Oncology Care in Algeria 3 General Oncology Care in Bahrain 4 General Oncology Care in Egypt 5 General Oncology Care in Iraq 6 General Oncology Care in Jordan 7 General Oncology Care in Kuwait 8 General Oncology Care in Lebanon 9 General Oncology Care in Libya 10 General Oncology Care in Mauritania 11 General Oncology Care in Morocco 12 General Oncology Care in Oman 13 General Oncology Care in Palestine 14 General Oncology Care in the Kingdom of Saudi Arabia 15 General Oncology Care in Somalia 16 General Oncology Care in Sudan 17 General Oncology Care in Syria 18 General Oncology Care in Tunisia 19 General oncology care in the UAE 20 General Oncology Care in the Republic of Yemen 21 General Oncology Care in Qatar, Comoros & Djibouti 22 Breast Cancer in the Arab World 23 Colorectal Cancer in the Arab World 24 Palliative Care in the Arab World 25 Cancer Research in the Arab World 26 Pediatric Oncology in the Arab World 27 Challenges Associated with Medical Travel for Cancer Patients in the Arab World: A Systematic Review 28 Radiation Therapy in Arab World 29 Cancer Care During War and Conflict
£999.99
Springer Verlag, Singapore Fundamentals in Gynaecologic Malignancy
Book SynopsisThis book is a complete representation of all the gynecological cancers covering from the anatomical details of the individual gynecological organs along with the epidemiological pathophysiological aspects of the various gynecological cancers. It also covers the diagnostic workup of various gynecological cancers with recent evidence based treatment protocols. All the major gynecological oncological surgeries are described in a simple way along with photographs for easy understanding in all the chapters. In addition, numerous flowcharts and management algorithms are included in every chapters, as a ready reference for the benefits of the trainees and practitioners. This book includes chapters such as critical care in oncology, oncology nursing, benign and malignant breast disease, hormones and gynecological cancer, cancer infections and vaccines, palliative care which are not often found in many text books. Apart from these, this book has also included chapters like principles and practice of Radiation oncology, surgical oncology and medical oncology, recent advances and imaging in gynecological malignancy to make it a complete package. Thus, it will serve as an excellent reference book for surgical oncologists, general gynecologists, medical and radiation oncologists fellows and trainees. Table of Contents1 Epidemiology of Gynaecological Cancers 2 Molecular profiling of Gynaecological Cancer and Breast Cancer 3 Tumour Biomarkers in Gynaecologic Oncology.4 Cancer: Infection and Vaccines.5 Imaging of Gynaecologic Malignancy6 Principles and practice of surgery in gynecological cancer7 Principles of Chemotherapy Targeted Therapy and Immunotherapy in Gynaecological Malignancies8 Principle and Practice of Radiation Oncology9 Benign Breast Diseases10 Breast Cancer11 Cervical Cancer Screening12 Management of precancerous lesions of cervix.13 Cancer of the uterine cervix14 Endometrial Cancer15 Uterine Sarcoma16 Epithelial Ovarian Cancer17 Malignant germ cell tumours of the ovary18 Stromal tumour of ovary19 Secondary Ovarian Tumor20 Fallopian tube Carcinoma21 Carcinoma Vulva22 Carcinoma Vagina 23 Gestational Trophoblastic Disease 24 Gynaecological Cancer in Pregnancy25 Role of MIS in Gynaecological Cancers 26 Hormone Replacement Therapy after Gynaecological Cancer27 The Perioperative and Critical Care Aspects in Gynaecology-Oncology28 Palliative Care in Advanced Gynecological Malignancy29 Gynaecological Cancers and Nursing30 Prevention and Screening in Gynecological Cancer31 Recent Advances in Gynaecological Cancer.
£113.99
Springer Verlag, Singapore Targeted Cancer Therapy in Biomedical Engineering
Book SynopsisThis book highlights the role of Biomedical Engineering (BME) used in diagnosis (e.g., body scanners) and treatment (radiation therapy and minimal access surgery in order to prevent various diseases). In recent years, an important progress has been made in the expansion of biomedical microdevices which has a major role in diagnosis and therapy of cancer. When fighting cancer, efficacy and speed are of the utmost importance. A recently developed microfluidic chip has enabled a breakthrough in testing the efficacy of specialized cancer drugs.Effective cancer-targeting therapies will require both passive and active targeting strategies and a thorough understanding of physiologic barriers to targeted drug delivery. Targeted cancer treatments in development and the new combinatorial approaches show promise for improving targeted anticancer drug delivery and improving treatment outcomes.This book discusses the advancements and innovations in the field of BME that improve the diagnosis and treatment of cancer. This book is focused on bioengineering approaches to improve targeted delivery for cancer therapeutics, which include particles, targeting moieties, and stimuli-responsive drug release mechanisms. This book is a useful resource for students, researchers, and professionals in BME and medicine.Table of ContentsStrategies for Cancer Targeting: Novel Drug Delivery Systems Opportunities and Future Challenges.- Implementation of Biomedical Engineering Tools in Targeted Cancer Therapy: Challenges and Opportunities.- Exploration of tissue-engineered systems for cancer research.- Advancement of Tissue Engineered in Cancer treatment.- Immunotherapy: Targeting Cancer Cells.- Bioinformatics Tools to Discover and Validate Cancer Biomarkers.- Application of Biomaterials in Cancer Research.- Engineered Tissue in Cancer Research: Techniques, Challenges and Current status.- CADD for Cancer Therapy: Current and Future Perspective.- Leveraging Advancement in Robotics in the Treatment of Cancer.-Innovative Biomedical Equipment for Diagnosis of Cancer.- Detection of Cancer Biomarker by Advanced Biosensor.- Advancement of Nanocarrier Based Engineering for Specific Drug Delivery for Cancer Therapy.- Nano-Drug Delivery Systems for Tumor-Targeting: Overcoming the Limitations of Chemotherapy.- Microfluidics and cancer treatment: Emerging concept of Biomedical Engineering.- Recent Developments In Two-Dimensional (2D) Inorganic Nanomaterials-Based Photo-Thermal Therapy for Cancer Theranostics.- Cyclodextrins and Cyclodextrin-Based Nanosponges for Anti-Cancer Drug and Nutraceutical Delivery.- Theranostic Approaches for Diagnosis and Treatment of Cancer: An Update.- MicroRNA Biomarkers for Oral Cancer: A Meta-Analytic Review.- Application of Magnetic Nanoparticles in Cancer: Drug Delivery and Therapy.- Vehicles for Delivery of Therapeutic Agent for Cancer Therapy.- Photothermal Therapy for Cancer Treatment.- Tool and Techniques on Computer -Aided Drug Design for Targeted Cancer Therapy.- Importance of Gut Microbiome-based Therapeutics in Cancer Treatment.- Computational Tools for Drug Discovery of Anticancer Therapy.- Stem Cell Therapy in Cancer
£999.99
Springer The Microbiome and Cancer
Book Synopsis.- Chapter 1_The Microbiome And Cancer: Understanding The Role Of Microorganisms In Tumor Development And Treatment..- Chapter 2_Microbiome And Its Impact On Human Health: Microbiome In Various Body Organs And Its Association With Human Health And Disease..- Chapter 3_Viral Infections And Different Cancers..- Chapter 4_Role Of Hcv In Hepatocellular Carcinoma..- Chapter 5_Cancers Associated With Epstein-Barr Virus..- Chapter 6_Human Papillomavirus Leading To Urogenital, Head And Neck Cancer..- Chapter 7_Kaposi's Sarcoma Associated Herpes Virus..- Chapter 8_Cancer And Fungal Infections..- Chapter 9_Microorganisms And Other Cancers..- Chapter 10_Protists And Cancer..- Chapter 11_Cancer Management And Therapies Related To Microorganisms.
£179.99
Springer Verlag, Singapore Diagnostic Imaging of Lung Cancers
Book SynopsisThis book systematically covers diagnostic imaging of lung cancers, including epithelial tumors, mesenchymal tumors, and hematolymphoid tumors, with emphasis on relationship between classification, molecular pathology, clinical findings, imaging manifestations and pathological discussion.
£999.99
Mark Sloan The Big 3: Heart Disease, Cancer, and Diabetes
Book Synopsis
£20.98